Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended-field IMRT With Concurrent Chemotherapy and Brachytherapy for Cervical Cancer
ChiCTR-OIC-17011347Phase 2Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin in Cervical Cancer (CC), sponsored by Peking Union Medical College Hospital. Primary endpoints: Acute toxic reactions and Chronic toxic reactions. Started Aug 2016; status: recruiting.
02
Drugs
cisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR-OIC-17011347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIC-17011347.